Baby formula recalled over bacterial contamination concerns

A manufacturer has recalled certain batches of two infant formula powders following fears that the products could be contaminated with bacteria.

Infant formula
Cronobacter sakazakii can cause fever and diarrhoea and in severe cases may lead to sepsis or meningitis

The UK Food Standards Agency (FSA) this week (January 3) said that manufacturer Reckitt had recalled two infant formula powders as a “precautionary step” because of the “possible presence of Cronobacter sakazakii”.

The affected products - Nutramigen LGG stage 1 and stage 2 Hypoallergenic Formula powders - are foods used for “special medical purposes” for infants that are mainly prescribed but are also available without a prescription, it added.

Read more: Boots baby formula ads breached marketing rules, finds watchdog

The FSA warned that symptoms caused by Cronobacter sakazakii usually include fever and diarrhoea and in severe cases may lead to sepsis or meningitis.

Reckitt has contacted all stores and pharmacies that are supplying these products and issued a recall notice to its customers, it added. 

“Thorough investigation”

The Reckitt recall notice, shared by the FSA, said that the recall was “due to an isolated overseas sample of the product testing positive for Cronobacter sakazakii” and will take place while the manufacturer continues to “conduct a thorough investigation”.

It warned patients not to use the batches but to return them to the pharmacy that dispensed them.

“At Reckitt, we are committed to the highest level of quality and safety, and the health and safety of infants is our highest priority,” it added.

A Reckitt spokesperson stressed that the manufacturer's own testing did not identify any positive results for the bacteria but that the voluntary recall is a result of possible contamination in product sampled by an independent party outside the U.S.

Affected products

The products being recalled are:

Nutramigen LGG Stage 1 Hypoallergenic Formula

  • Pack size: 400g
  • Batch code: ZL3F7D
  • Best before: 01 July 2025

Nutramigen LGG Stage 2 Hypoallergenic Formula

  • Pack size: 400g
  • Batch code: ZL3FAA
  • Best before: 01 July 2025

Nutramigen LGG Stage 2 Hypoallergenic Formula

  • Pack size: 400g
  • Batch code: ZL3FDM
  • Best before: 01 July 2025

Read more: Eye gels recalled due to 'possible microbial contamination', MHRA warns

Reckitt’s recall notice confirmed that “no other batches of Nutramigen LGG Stage 1 and stage 2 are affected and these remain safe to use”. 

“No other Nutramigen products in the range are affected”, it added. 

C+D approached Reckitt for comment.

Sign in or register for free

Costanza Potter

Read more by Costanza Potter

Cos Potter joined C+D as its news editor in December 2022 but has been covering primary care news for over five years. After starting out at the pharmacy press in 2019, she worked at a GP title for several years before the pharmacy sector beckoned her back.

Latest from News

Patient secures ‘urgent’ leukaemia treatment after Pharmacy First consultation

 
• By 
 • comment

A pharmacist has been hailed as “incredible” after she spotted a patient’s leukaemia red flags during an NHS Pharmacy First Plus consultation.

PDA releases ‘six-step test’ for the next funding contract

 
• By 
 • comment

It assesses whether the next funding contract will support pharmacists, keep patients safe, and offer long-term sustainability.

Assisted dying: Pharmacists’ voices are ‘missing’ from dialogue

 
• By 
 • comment

Experts have long been calling for pharmacists to be able to conscientiously object to taking part in the assisted dying process, but one researcher argues that pharmacists’ voices are “missing” from this dialogue.

More from Clinical

Pharmacy stop-smoking service expands to ‘non-registered’ staff

 
• By 
 • comment

The new pharmacy contract has expanded who can deliver the smoking cessation service, as well as adding the provision of two drugs via PGDs.

Antidepressants added to NMS from October

 
• By 
 • comment

The government has announced an expansion to and fresh payment structure for the new medicine service (NMS) to “boost mental health support in the community”.